Published in JAMA on August 20, 1997
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Ghost authorship in industry-initiated randomised trials. PLoS Med (2007) 4.95
Criteria for authorship in bioethics. Am J Bioeth (2011) 4.60
Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ (2011) 4.44
Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ (2013) 3.51
A systematic review of research on the meaning, ethics and practices of authorship across scholarly disciplines. PLoS One (2011) 2.75
Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol (2004) 2.34
Who wrote this paper anyway?The new Vancouver Group statement refines the definition of authorship. CMAJ (2000) 1.98
How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ (2002) 1.95
Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Med (2007) 1.86
New target regions for human hypertension via comparative genomics. Genome Res (2000) 1.75
What should be done to tackle ghostwriting in the medical literature? PLoS Med (2009) 1.72
Authorship policies of bioethics journals. J Med Ethics (2011) 1.63
"Equal" contributions and credit: an emerging trend in the characterization of authorship. Ann Epidemiol (2010) 1.57
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors. Rheumatol Int (2012) 1.52
Growth and decentralization of the medical literature: implications for evidence-based medicine. J Med Libr Assoc (2005) 1.50
Publish together or perish: the increasing number of authors per article in academic journals is the consequence of a changing scientific culture. Some researchers define authorship quite loosely. Dtsch Arztebl Int (2008) 1.48
Promoting transparency in pharmaceutical industry-sponsored research. Am J Public Health (2011) 1.46
Coauthorship in pathology, a comparison with physics and a survery-generated and member-preferred authorship guideline. MedGenMed (2004) 1.45
Perceptions of authorship criteria: effects of student instruction and scientific experience. J Med Ethics (2007) 1.42
Are the authors listed on that paper really the authors? MedGenMed (2005) 1.40
Authors, ghosts, damned lies, and statisticians. PLoS Med (2007) 1.38
If authors became contributors, everyone would gain, especially the reader. Am J Public Health (1998) 1.37
Measuring co-authorship and networking-adjusted scientific impact. PLoS One (2008) 1.30
Integrity in scientific publishing. Health Serv Res (2010) 1.27
Fraudulent human embryonic stem cell research in South Korea: lessons learned. Account Res (2006) 1.25
Automated construction of high-density comparative maps between rat, human, and mouse. Genome Res (2001) 1.24
Separating authorship responsibility and authorship credit: a proposal for biomedical journals. Am J Public Health (1998) 1.22
How industry uses the ICMJE guidelines to manipulate authorship--and how they should be revised. PLoS Med (2011) 1.13
Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries. BMC Med Ethics (2014) 1.09
Publishing clinical trial results: the future beckons. PLoS Clin Trials (2006) 1.02
Who did what? Uneasiness with the current authorship is prompting the scientific community to seek alternatives. EMBO Rep (2004) 1.01
Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med (2014) 0.92
The prevalence of honorary and ghost authorships in Iranian bio-medical journals and its associated factors. Iran J Public Health (2011) 0.89
Authorship of research papers: ethical and professional issues for short-term researchers. J Med Ethics (2006) 0.89
New policy on disclosures at Health Services Research. Health Serv Res (2006) 0.85
Re: authors and authorship. Am J Public Health (1998) 0.85
Re: authors and authorship. Am J Public Health (1998) 0.84
Byline corruption can only be controlled by true stakeholders. MedGenMed (2004) 0.84
Authorship policies of scientific journals. J Med Ethics (2015) 0.83
Authorship and contributorship in scholarly journals. J Korean Med Sci (2013) 0.83
Authorship matrix: a rational approach to quantify individual contributions and responsibilities in multi-author scientific articles. Sci Eng Ethics (2013) 0.82
Equal contributions and credit: an emerging trend in the characterization of authorship in major anaesthesia journals during a 10-yr period. PLoS One (2013) 0.81
The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage (2011) 0.79
Authorship: attitudes and practice among Norwegian researchers. BMC Med Ethics (2014) 0.79
Whose manuscript is it anyway? The 'Write' position and number of authors…. J Indian Soc Periodontol (2013) 0.79
Transgression in scientific communication. Indian J Anaesth (2010) 0.78
Authorship Inflation in Medical Publications. Inquiry (2015) 0.77
Medical ghost-writing. Mens Sana Monogr (2008) 0.77
Bibliometric assessment of publication output of child and adolescent psychiatric/psychological affiliations between 2005 and 2010 based on the databases PubMed and Scopus. Eur Child Adolesc Psychiatry (2012) 0.77
Authorship issues related to software tools. J Am Med Inform Assoc (2007) 0.77
The ICMJE Recommendations and pharmaceutical marketing - strengths, weaknesses and the unsolved problem of attribution in publication ethics. BMC Med Ethics (2016) 0.76
Moving the conflicted issue of authorship forward with data. MedGenMed (2004) 0.75
Authors vs contributors: accuracy, accountability, and responsibility. JAMA (1998) 0.75
Co-author responsibility: Distinguishing between the moral and epistemic aspects of trust. EMBO Rep (2014) 0.75
Authors vs contributors: accuracy, accountability, and responsibility. JAMA (1998) 0.75
Response to "the corporate coauthor". J Gen Intern Med (2005) 0.75
Best practices for allocating appropriate credit and responsibility to authors of multi-authored articles. Front Psychol (2011) 0.75
Peer review under scrutiny. Report on the third International Congress in Prague, 1997. Can Fam Physician (1998) 0.75
Plus ça change... CMAJ (1997) 0.75
Faculty Member's Views, Attitude and Current Practice As Regards International Committee of Medical Journal Editors Criteria for Authorship. Iran J Public Health (2013) 0.75
Of credence and credibility: A year gone by. Indian J Radiol Imaging (2014) 0.75
Authorship Issues and Conflict in the U.S. Academic Chemical Community. Account Res (2015) 0.75
How to define an author? Awareness of authorship criteria. Anesth Pain Med (2013) 0.75
Authors, authorship order, the moving finger writes. J Indian Soc Periodontol (2015) 0.75
Authorship trends in the Indian Journal of Pathology and Microbiology: going the global way? J Clin Pathol (2004) 0.75
How to Write a Scientific Paper: Practical Guidelines. EJIFCC (2014) 0.75
Good season ahead. Croat Med J (2011) 0.75
Do we know and apply the principles of academic authorship? Ethiop J Health Sci (2012) 0.75
On Ghosts and Other Unwelcome Guests. J Gen Intern Med (2015) 0.75
A medical early warning system. CMAJ (2002) 0.75
Authors vs contributors: accuracy, accountability, and responsibility. JAMA (1998) 0.75
Ten Simple Rules for Protecting Research Integrity. PLoS Comput Biol (2015) 0.75
Authors vs contributors: accuracy, accountability, and responsibility. JAMA (1998) 0.75
Ethics of authorship in scientific publications. Trop Parasitol (2013) 0.75
Sources of concern about the Patient Self-Determination Act. N Engl J Med (1991) 3.90
The contributions of authors. JAMA (2000) 1.91
Disclosure to the reader of institutional review board approval and informed consent. JAMA (1997) 1.55
Are acting and omitting morally equivalent? A reappraisal. J Am Geriatr Soc (1995) 1.45
If authors became contributors, everyone would gain, especially the reader. Am J Public Health (1998) 1.37
Advance care planning for children with special health care needs: a survey of parental attitudes. Pediatrics (1996) 1.09
Psychometric analysis of an advance directive. Med Care (1996) 0.90
Comparing utilization of life-sustaining treatments with patient and public preferences. J Gen Intern Med (1998) 0.89
Two-year weight-loss maintenance in primary care-based Diabetes Prevention Program lifestyle interventions. Nutr Diabetes (2013) 0.89
Appropriate and inappropriate use of advance directives. J Clin Ethics (1994) 0.83
Bringing market medicine to professional account. JAMA (1997) 0.83
The efficacy of professional ethics. The AMA code of ethics in historical and current perspective. Hastings Cent Rep (2000) 0.79
The AMA, tobacco, and the public health. JAMA (1996) 0.75
How living wills can help doctors and patients talk about dying. BMJ (2000) 0.75
[Utilization of glucose and changes in the concentration of volatile fatty acids in kids during the 1st 5 months of life]. Vet Med (Praha) (1974) 0.75
Institute for Medical Ethics faces up to flood of dilemmas. BMJ (1997) 0.75
[Myxedematous changes of pre-tibial collagen tissue]. Cesk Dermatol (1968) 0.75